Literature DB >> 22843853

Shedding of kidney injury molecule-1 by membrane-type 1 matrix metalloproteinase.

Luyang Guo1, Takahisa Takino, Yoshio Endo, Takahiro Domoto, Hiroshi Sato.   

Abstract

Co-expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) with kidney injury molecule-1 (KIM-1) in HEK293T cells resulted in cleavage and shedding of KIM-1 ectodomain. Analysis of cleavage products using KIM-1 mutants localized cleavage site at the juxtamembrane region. HT1080 cells were stably transfected with expression plasmid for KIM-1 or its mutant with deletion of the juxtamembrane region (Asp(261)-Gly(295)) to establish HT/KIM-1 or HTKIM-1 cells, respectively. KIM-1 protein appeared on cell surface at low level in HT/KIM-1 cells, and accumulated by the treatment with MMP inhibitor BB-94 or small interfering RNA (siRNA) to MT1-MMP, indicating that MT1-MMP is involved in cleavage and shedding of KIM-1. In contrast, HTKIM-1 cells expressed KIM-1 protein at high level regardless of BB-94 or siRNA treatment. Cells expressing high level KIM-1 protein exhibited phagocytosis of Escherichia coli and reduced cell adhesion and spreading on collagen-coated plate compared with KIM-1 negative cells. Control HT1080 and HT/KIM-1 cells showed significantly higher invasive growth in collagen gel, cell migration on collagen-coated plate and liver metastasis in chick embryo than HTKIM-1 cells. These results suggest that KIM-1 negatively regulates cellular function mediated through interaction with collagen, and MT1-MMP abrogates it through the cleavage and shedding of KIM-1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843853     DOI: 10.1093/jb/mvs082

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).

Authors:  Katja Möller-Hackbarth; Christin Dewitz; Olga Schweigert; Ahmad Trad; Christoph Garbers; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

2.  Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo.

Authors:  Hongrui Cui; Guangwei Ren; Xiuhong Hu; Baozhen Xu; Yuping Li; Zheli Niu; Liqin Mu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

Authors:  Saranga Sriranganathan; Elena Tutunea-Fatan; Alina Abbasi; Lakshman Gunaratnam
Journal:  Mol Cell Biochem       Date:  2020-11-19       Impact factor: 3.396

4.  KIM-1 and NGAL as biomarkers of nephrotoxicity induced by gentamicin in rats.

Authors:  Qi-hui Luo; Meng-lu Chen; Feng-jiao Sun; Zheng-li Chen; Ming-yang Li; Wen Zeng; Li Gong; An-chun Cheng; Xi Peng; Jing Fang; Li Tang; Yi Geng
Journal:  Mol Cell Biochem       Date:  2014-08-03       Impact factor: 3.396

5.  Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis.

Authors:  Rushi Gandhi; James Yi; Jihyen Ha; Hang Shi; Ola Ismail; Sahra Nathoo; Joseph V Bonventre; Xizhong Zhang; Lakshman Gunaratnam
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-14

6.  Establishment of Simple and Routine Methods in Early Diagnosis of Gentamicin-Induced Kidney Injury Based on a Rat Model.

Authors:  Cuiyan Liu; Youxi Kang; Huiqin Zhang; Long Zhu; Hai Yu; Chunyang Han
Journal:  Biomed Res Int       Date:  2016-08-18       Impact factor: 3.411

Review 7.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

8.  TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.

Authors:  Liuyan Chen; Jilin Qing; Yangyang Xiao; Xiaomei Huang; Yanlin Chi; Zhizhong Chen
Journal:  BMC Cancer       Date:  2022-04-07       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.